We clearly understand our customer needs and use cutting edge technology to present innovative solutions. Our business includes Branded Generics in emerging markets of Asia and Africa.

The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia.

In India we have presence in high growth specialty segments of cardiology, dermatology, ophthalmology and pain management where we have been able to provide consistently innovative products, many being 1st to the market, for patient convenience and compliance.

Emerging markets are the major contributors in our branded generic business where we are present across Asia and Africa. We have designed customised basket of products for each of these markets and serve wide range of therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products.

Umang pharmatech® operates with 5 state-of-the-art manufacturing facilities that produce high quality pharmaceutical products. Currently one of the facility is approved by GMP and another facility is getting ready for WHO-GMP. We are further expanding our manufacturing capabilities to meet our growth requirement in future.

We have an advanced Research & Development Centre for finished formulations of different dosage forms. Our R&D centre has a team of over 10 scientists working on innovative products for various markets across the globe. We have acquired strong capabilities for developing generic formulations and process chemistry over the years.

We employ over 120 people worldwide and our products are sold in over 30 countries. Umang pharmatech® team members are driven to fulfill its mission a commitment to 'Serving Global Healthcare needs with Empathy, Innovation & Technology